Oct.22-28, 2008, Beijing, China
Organizers & SAB
---------------------------------------------------------------------------------------------------------------------------------------------------------
Chair
Hailin Liu
(Deputy Director General, China Medicinal Biotech Association, China)

Co-Chair
Ziren Xiao (Deputy Director General, China Medicinal Biotech Association, China)

Executive Chair and Secretary General
Xiaodan Mei (President, Dalian BIT Life Sciences, Inc.)

Deputy Secretary General
Zhaohui Wu (Assistant Secretary General, China Medicinal Biotech Association, China)
Yuefen Chang (Assistant Secretary General, China Medicinal Biotech Association, China)

Membership
Yong Wen (Superior, Membership Department of China Medicinal Biotech Association, China)

Program Leader
Helen Zhao (Director, Dalian BIT Life Sciences, Inc.)

Program Coordinator
Zaylin Zhang (Group Member of Dalian BIT Life Sciences, Inc.)
Vicky Zhu (Group Member of Dalian BIT Life Sciences, Inc.)
Chris Han (Group Member of Dalian BIT Life Sciences, Inc.)

SAB Members
Victor Shi, President of QIAGEN Asia
Julian Burke,
CSO and a Main Board Director, Genetix Group plc., UK
Sandeep Gulati, CSO of ViaLogy Corp.
Jan Mous, President and CEO, IntegraGen SA
John Jiang, Principal Scientist, Veridex, LLC, USA
Songming Chen, Research Scientist of Van Andel Research Institute (VARI), USA
Harald Berninge, Director Sales and Marketing, Kreatech Diagnostics, The Netherlands
Caifu Chen, Scientific Fellow, Molecular Cell Biology Division, Sr. Director, Assays R&D, Applied Biosystems, USA
Robert H. Getzenberg, The Donald S. Coffey Professor, Director of Urology Research, Brady Urological Institute
Professor of Urology, Oncology and Pharmacology and Molecular Sciences, Johns Hopkins Hospital, USA
Subhas Chakrabarty, Professor and Associate Dean of Basic Sciences, SIU Cancer Institute., USA
Roberto Sitia,
Professor of Cell and Molecular Biology, Vita-Salute University, Italy
Eric Chen,
Director, Applied Molecular Profiling Laboratory (AMPL) Toronto, Ontario, Canada
Giuseppe Chiumello, Diretor, University Vita-Salute San Raffaele, Italy
Jennifer A. Byrne, Head, Molecular Oncology, Oncology Research Unit at The Children's Hospital at Westmead, Australia
Karol Sikora, Medical Director of Cancer Partners, UK
Leif Groop, Professor of Department of Clinical Sciences, Diabetes andEndocrinology Research Unit, Lund UniversityDiabetes Centre, Lund University, Sweden
Paul Andrew Checchia, Department of Pediatrics, Division of Critical Care, Washington University School of Medicine, USA
Wei Zhang, Professor and Director of Cancer Genomics Core Laboratory, Texas, USA
Akex Van Belkum, Chairperson of Erasmus MC., The Netherlands
Abdurrahman Coskun, Department of Clinical Biochemistry, Duzce University, School of Medicine, Duzce, Turkey
Chularut Prariyachatigul, Assistant Professor, Department of Clinical Microbiology, Faculty of Associated Medical Sciences, Khon Kaen University, Thailand
Li Cai, Director, Molecular Genetics and Molecular Oncology, Laboratory Corporation of America, Center for Molecular Biology and Pathology, USA
Fabrice Fekam Boyom, Department of Biochemistry, Faculty of Science, University of Yaound¨¦, Cameroon
Berninger, Harald, Director Sales and Marketing, Kreatech Diagnostics, The Netherlands
Michal Daniely, Biology R&D Manager, BioView Ltd., Israel
Shibin Qiu, Senior Scientist, Pathwork Diagnostics Inc
Stephen P. Squinto, Executive Vice President and Head of Research,Alexion Pharmaceuticals Inc, USA
Xiao Zeng, Senior Director, R&D and Business Development, SuperArray, USA
Zhi-Gang Jiang, Program Director, Neurodegenerative Diseases, Panacea Pharmaceuticals, Inc., USA
Joep C. Defesche, Department of Vascular Medicine, Academic Medical Centre at the University of Amsterdam, the Netherlands
Condie E. Carmack, Program Manager, Microarrays, Diagnostics, Life Sciences Solutions Unit, Agilent Technologies, Inc., USA
Qiang Xu, Pricinpal scientitst, Head of Bioinformatics, AltheaDx Inc., USA.
David Perlin, Director and Professor, Public Health Research Institute, UMDNJ-New Jersey Medical School, USA
Ursula Scheefers-Borchel, biochemists and molecular biologists, founder, ScheBo Biotech AG, Germany
Sharif Akhteruzzaman, Professor, Department of Biochemistry and Molecular Biology, University of Dhaka, Bangladesh
Antonius Schuh, Chief Executive Officer , AviaraDx, Inc., USA
Hsian-Rong Tseng, Assistant Professor, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, UCLA., USA
Willy A. Valdivia-Granda, CEO, Orion Integrated Biosciences Inc., USA
Joseph Nadeau, Chair/Professor, Department of Genetics, School of Medicine, Case Western Reserve University, USA
T. V. Moorthy, President/CEO, MultiGEN Diagnostics Inc, USA
Raymond Lin, Associate Professor Raymond Lin, Clinical Director, Molecular Diagnosis Centre, National University Hospital , Singapore
Han-Oh Park, President and CEO, Bioneer Corporation, Korea
David W. Moskowit, Chairman, CEO & Chief Medical Officer, GenoMed, Inc., USA
Joel Slomoff, Fulbright & Jaworski L.L.P., Washington, DC., USA

Moreˇ­

 
© 2008 All right reserved for BIT Life Sciences
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629